Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The protein structure and effect of factor VIII.

Hong Fang1, Lemin Wang, Hongbao Wang

  • 1Department of Cardiology, Tongji Hospital, Tongji University, Shanghai 200065, China. de_61@Yahoo.com.cn

Thrombosis Research
|February 21, 2006
PubMed
Summary

Factor VIII (FVIII), crucial for blood clotting, becomes active cofactor FVIIIa after protease cleavage. This active form significantly enhances the coagulation cascade, and its variants can cause bleeding disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomized, Placebo-Controlled, Multicenter Clinical Study on the Efficacy and Safety of Lidocaine Patches in Chinese Patients with Postherpetic Neuralgia.

Dermatology and therapy·2023
Same author

Rare tumors: a blue ocean of investigation.

Frontiers of medicine·2023
Same author

Treatment of primary cutaneous lichenoid amyloidosis with abrocitinib: A pilot study in two cases.

International journal of dermatology·2023
Same author

Adverse events of PD-(L)1 inhibitors plus anti-VEGF(R) agents compared with PD-(L)1 inhibitors alone for cancer patients: a systematic review and meta-analysis.

Frontiers in pharmacology·2023
Same author

CircHIPK2 facilitates phenotypic switching of vascular smooth muscle cells in hypertension.

Journal of human hypertension·2023
Same author

Clinical Features and Skin Microbiome of Tinea Scrotum: An Observational Study of 113 Cases in China.

Mycopathologia·2023

Area of Science:

  • Biochemistry
  • Hematology
  • Molecular Biology

Background:

  • Factor VIII (FVIII) is essential for blood coagulation.
  • Protease activity cleaves FVIII into its active form, FVIIIa.
  • FVIIIa is a trimer with A1, A2, and A3-C1-C2 subunits.

Purpose of the Study:

  • To elucidate the structural alterations and functional activation of Factor VIII.
  • To understand the role of FVIIIa in the coagulation cascade.
  • To highlight the implications of FVIII variants in bleeding disorders.

Main Methods:

  • Analysis of protease cleavage sites on FVIII.
  • Characterization of the active FVIIIa trimeric structure.
  • Investigation of FVIIIa's cofactor activity in factor X activation.

Related Experiment Videos

Main Results:

  • FVIII is cleaved at three specific sites (two heavy, one light chain) to form active FVIIIa.
  • FVIIIa, a trimer, significantly boosts the catalytic efficiency of factor IXa.
  • Structural changes lead to FVIII's transition from inactive to active cofactor.

Conclusions:

  • Factor VIII activation involves specific proteolytic cleavage and conformational changes.
  • Active FVIIIa is critical for efficient blood coagulation by enhancing factor X activation.
  • Genetic variations in FVIII are linked to severe bleeding disorders, underscoring its clinical importance.